article thumbnail

23andMe to launch GLP-1 telehealth offering, shuts down internal drug development business

FierceHealthIT

23andMe plans to launch a GLP-1 weight loss telehealth membership through its Lemonaid Health platform by the end of the month. Consumer genetic testing company 23andMe sees an opportunity to get in on the weight loss boom.

article thumbnail

COVID-19 has accelerated adoption of non-contact patient monitoring technology, says Frost & Sullivan analysis

Healthcare IT News - Telehealth

telehealth market, which will experience a significant increase due to mobile platform technology. “These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

Telehealth and Virtual Care: The pandemic accelerated the adoption of telehealth, and this trend is expected to continue, boosting valuations for companies providing innovative virtual care solutions.

article thumbnail

Questions prompt potential privacy expansion in interop rule

Morning eHealth

Where’s the telehealth rule? — AI and drug development

article thumbnail

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

Regulatory Landscape: Changes in regulatory frameworks, such as the easing of restrictions on telehealth, will create new opportunities for M&A. Specific predictions for 2025: AI-powered drug discovery: A major pharmaceutical company may acquire a European AI-driven drug discovery startup to accelerate its pipeline development.

article thumbnail

In Health Care, AI to Advance Rapidly Along With Its Regulation

Healthcare IT Today

He also said that the benefits go beyond doctors; for instance, care coordinators can be more efficient and AI can help drug development. Both believe that AI can deliver primary care through telehealth to regions that lack it and to marginalized communities.

article thumbnail

Labcorp teams up with Ascension to expand services in several states

Healthcare IT News - Telehealth

The companies drew particular attention to Labcorp Drug Development, which Ascension says it can use to present physicians and patients with access to clinical trials, innovative therapies and new treatment options where appropriate. Labcorp also said it would use proprietary analytic tools and processes to improve overall efficiency.